Michard Baptiste, Artzner Thierry, Lebas Benjamin, Besch Camille, Guillot Max, Faitot François, Lefebvre François, Bachellier Philippe, Castelain Vincent, Maestraggi Quentin, Schneider Francis
Service de Réanimation Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
FMTS, Faculté de Médecine de Strasbourg, Université de Strasbourg, Strasbourg, France.
Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13115. Epub 2017 Oct 31.
The allocation of liver transplants to patients with acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) with multi-organ failure who are admitted in ICU remains controversial due to their high post-transplant mortality rate and the absence of identified mortality risk factors.
We performed a single-center retrospective cohort study to determine the post-transplant mortality rate of patients with ALF and ACLF requiring ICU care prior to liver transplant (LT) and identified pretransplant factors of post-transplant mortality.
Eighty-four patients (29 with ALF and 55 with ACLF) received a liver transplant while they were hospitalized at the ICU. Their mean model for end-stage liver disease (MELD) score was 41, and their mean sequential organ failure assessment (SOFA) was 15 the day before transplant. The overall 1-year survival rate was 66%. In multivariate analysis, pretransplant lactate level and acute respiratory distress syndrome (ARDS) were the only two independent factors associated with post-transplant mortality. The absence of ARDS and a pretransplant lactate level< 5 mmol/L led to the identification of a subgroup of ICU patients with a good 1-year post-transplant survival (>80%).
Low lactatemia lactate level and the absence of ARDS could be useful criteria in selecting those patients in ICU who could be eligible for liver transplant.
由于急性肝衰竭(ALF)和慢性肝衰竭急性发作(ACLF)伴多器官衰竭且入住重症监护病房(ICU)的患者移植后死亡率高,且缺乏明确的死亡风险因素,因此将肝移植分配给这类患者仍存在争议。
我们进行了一项单中心回顾性队列研究,以确定肝移植(LT)前需要ICU护理的ALF和ACLF患者的移植后死亡率,并确定移植后死亡的移植前因素。
84例患者(29例ALF和55例ACLF)在ICU住院期间接受了肝移植。他们的平均终末期肝病模型(MELD)评分是41分,移植前一天的平均序贯器官衰竭评估(SOFA)评分是15分。总体1年生存率为66%。在多变量分析中,移植前乳酸水平和急性呼吸窘迫综合征(ARDS)是与移植后死亡率相关的仅有的两个独立因素。不存在ARDS且移植前乳酸水平<5 mmol/L可确定一组移植后1年生存率良好(>80%)的ICU患者亚组。
低乳酸血症和不存在ARDS可能是选择那些有资格接受肝移植的ICU患者的有用标准。